Therapeutic outcome of self withdrawn patients
| Patient No | PV3-150(mPa.s) | CRP3-150(mg/l) | AI3-150 | MS3-150(min) | PS3-150 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Entry | Exit | Entry | Exit | Entry | Exit | Entry | Exit | Entry | Exit | ||||||||||
| 10 (CG3-150) | 1.95 | 1.85 | 234 | 93 | 52 | 62 | 441 | 205 | 3.85 | 4.00 | |||||||||
| 30 (CG | 1.78 | 1.79 | 91 | 124 | 36 | 28 | 107 | 110 | 3.00 | 2.65 | |||||||||
| 37 (CG) | 1.66 | 1.75 | 51 | 28 | 38 | 32 | 139 | 132 | 3.85 | 3.21 | |||||||||
| 40 (CG) | 1.84 | 1.86 | 5 | <5 | 24 | 24 | 45 | 45 | 2.00 | 2.00 | |||||||||
| 45 (CG) | 1.85 | 1.89 | 101 | 60 | 34 | 31 | 282 | 282 | 3.64 | 3.64 | |||||||||
| 49 (CG) | 1.96 | 2.00 | 21 | 32 | 15 | 27 | 12 | 25 | 3.00 | 3.64 | |||||||||
| 58 (CG) | 1.71 | 1.64 | 20 | <5 | 19 | 2 | 120 | 00 | 3.40 | 4.00 | |||||||||
| 60 (CG) | 1.82 | NS3-150 | 121 | 81 | 21 | 21 | 120 | 120 | 3.00 | 3.00 | |||||||||
| 64 (CG) | 2.15 | 1.80 | 100 | 51 | 35 | 4 | 600 | 153 | 5.00 | 2.57 | |||||||||
| 67 (EG3-150) | 1.81 | 1.80 | 48 | 146 | 31 | 20 | 180 | 578 | 5.00 | 4.78 | |||||||||
| 73 (CG) | 1.79 | 1.79 | <5 | <5 | 27 | 30 | 70 | 12 | 3.50 | 3.64 | |||||||||
| 85 (CG) | 2.05 | 1.94 | 81 | 28 | 14 | 00 | 120 | 00 | 4.00 | 2.00 | |||||||||
| 87 (CG) | 1.87 | 2.00 | 55 | 37 | 37 | 29 | 600 | 600 | 4.30 | 3.57 | |||||||||
| 97 (EG) | 1.60 | 1.70 | 21 | 14 | 20 | 20 | 10 | 10 | 4.00 | 4.00 | |||||||||
↵3-150 PV = plasma viscosity; CRP = C reactive protein; AI = articular index; MS = morning stiffness; PS = pain score; CG = control group; EG = experimental group; NS = no sample.